Your Patient Needs Bonjesta — Now What?

You've determined that Bonjesta is the right treatment for your patient's nausea and vomiting of pregnancy. The prescription is sent. Then you get the call: the pharmacy doesn't have it in stock. Or worse — the patient gives up looking and goes without treatment.

This is a common scenario in 2026. While Bonjesta is not in a formal supply shortage, limited pharmacy stocking means your patients often face real barriers to filling their prescriptions. As a provider, there are concrete steps you can take to improve the odds. For a broader overview of the current availability landscape, see our provider shortage briefing.

Current Availability Snapshot

Key facts as of March 2026:

• Bonjesta is manufactured and distributed normally by Duchesnay USA — no FDA or ASHP shortage listing
• Many chain pharmacies (CVS, Walgreens, Rite Aid) do not routinely stock it due to high wholesale cost (~$481–$490 for 30 tablets) and low prescription volume
• Independent pharmacies are more likely to special-order but may not carry it on hand
• The Bonjesta At Home mail-order program remains the most reliable access point
• No generic version is available; patents extend through 2033

Why Patients Can't Find Bonjesta

Understanding the root causes helps you counsel patients effectively:

1. Brand-name exclusivity: No generic competition means higher wholesale cost and lower pharmacy incentive to stock
2. Niche indication: NVP-specific medications have a smaller patient pool than most chronic disease drugs
3. Insurance friction: Prior authorization and step therapy requirements reduce prescription volume, which reduces stocking
4. Price sensitivity: At nearly $500 cash price, pharmacies avoid carrying inventory that may not move

What Providers Can Do: 5 Actionable Steps

Step 1: Use Medfinder to Identify Stocking Pharmacies

Medfinder for Providers lets you search for pharmacies with Bonjesta in stock near your patient's location. Instead of sending patients on a calling marathon, you can direct them to a specific pharmacy that has it. Consider integrating this into your prescribing workflow — check availability before or at the time of prescribing.

Step 2: Send the Prescription to a Pharmacy That Stocks It

Rather than defaulting to the patient's usual chain pharmacy, direct the e-prescription to a pharmacy confirmed to have Bonjesta in stock. This single step eliminates the most common point of failure. If you use Medfinder, the identified pharmacy information can be given directly to the patient or used for e-prescribing.

Step 3: Enroll Patients in Bonjesta At Home

For patients who face persistent local availability issues, the Bonjesta At Home mail-order program is the most reliable pathway:

• Uninsured patients pay $60 for 30 tablets or $99 for 60 tablets
• Free home delivery
• On-staff pharmacists available for patient questions
• Insurance assistance support
• Phone: 1-800-835-0755

Consider keeping Bonjesta At Home enrollment materials in your office for easy distribution.

Step 4: Proactively Initiate Prior Authorization

If the patient is commercially insured, prior authorization is likely required. Best practices:

• Document trial and failure of OTC vitamin B6 and generic doxylamine/pyridoxine (Diclegis generic) in the chart
• Specify the clinical rationale for Bonjesta — adherence advantages of 1-2 tablets/day vs. up to 4/day, or breakthrough symptoms with delayed-release-only formulations
• Submit prior authorization at the time of prescribing, not after the pharmacy rejection, to avoid delays

Step 5: Provide the Manufacturer Savings Card

For commercially insured patients, the Bonjesta CoPay Savings Card can reduce out-of-pocket costs to as low as $35–$40 per prescription. The card is available at bonjesta.com/bonjesta-savings and can be downloaded and printed by the patient or provided in-office.

Alternatives to Consider

If Bonjesta access proves insurmountable for a given patient, the following alternatives are the most appropriate substitutes. For a patient-facing comparison, see our alternatives guide:

• Generic Diclegis (doxylamine/pyridoxine DR 10 mg/10 mg): Same active ingredients, delayed-release only, up to 4 tablets/day. Cost: ~$30–$80 for 60 tablets.
• Ondansetron (Zofran) generic: 5-HT3 antagonist, used off-label for NVP. Cost: ~$10–$30. Less sedating but different mechanism of action.
• Promethazine (Phenergan) generic: First-generation antihistamine/antiemetic. Cost: ~$5–$20. Significant sedation.
• Metoclopramide (Reglan) generic: Dopamine antagonist/prokinetic. Cost: ~$10–$25. Generally second/third-line due to side effect profile.

Workflow Tips for Your Practice

Integrating these steps into your practice workflow can make the process smoother:

• Pre-prescribing availability check: Before sending the Bonjesta e-script, have a staff member check Medfinder for nearby pharmacy stock
• Stock Bonjesta At Home materials: Keep enrollment brochures and the phone number (1-800-835-0755) in exam rooms or at the front desk
• Template prior authorization letters: Create a template that documents step therapy failure and clinical rationale for Bonjesta specifically
• Patient handout: Consider creating a one-page handout covering savings options, the Bonjesta At Home program, and how to use Medfinder — this reduces follow-up calls to your office
• Flag in EHR: If your EHR supports prescribing alerts or notes, add a reminder about the stocking issue and available savings programs when Bonjesta is prescribed

Final Thoughts

The gap between prescribing Bonjesta and patients actually filling it is a real clinical problem. But with proactive steps — directing prescriptions to pharmacies confirmed to have stock, enrolling patients in savings programs, and completing prior authorization upfront — you can significantly improve your patients' access.

Tools like Medfinder for Providers are designed to make this easier. By spending a few extra minutes during the prescribing process, you can save your patients hours of frustration — and ensure they actually get the relief they need from morning sickness.

For the patient-facing version of this information, direct your patients to our guide on finding Bonjesta in stock. For cost-saving information to share, see how to save money on Bonjesta.